Youcare Pharmaceutical Group Co., Ltd. (SHA:688658)
China · Delayed Price · Currency is CNY 13.26
-0.36 (-2.64%)
Sep 2, 2026, 3:00 PM CST
SHA:688658 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 708.96 | 1,022 | 1,333 | 1,483 | 1,661 | 2,437 |
Trading Asset Securities | 626.62 | 397.81 | 160.26 | - | - | - |
Cash & Short-Term Investments | 1,336 | 1,420 | 1,493 | 1,483 | 1,661 | 2,437 |
Cash Growth | 7.46% | -4.91% | 0.72% | -10.76% | -31.84% | -3.88% |
Accounts Receivable | 594.7 | 602.59 | 805.43 | 1,094 | 1,366 | 927.02 |
Other Receivables | 8.67 | 2.25 | 13.56 | 1.58 | 0.22 | 2.28 |
Receivables | 603.37 | 604.84 | 818.99 | 1,095 | 1,366 | 929.3 |
Inventory | 409.65 | 465.11 | 757.34 | 727.69 | 738.34 | 632.31 |
Other Current Assets | 124.67 | 99.37 | 88.44 | 119.24 | 135.64 | 66.91 |
Total Current Assets | 2,473 | 2,589 | 3,158 | 3,425 | 3,901 | 4,066 |
Property, Plant & Equipment | 1,934 | 2,002 | 1,999 | 1,960 | 1,671 | 1,302 |
Long-Term Investments | 228.42 | 150.3 | 33.1 | 15.75 | - | - |
Other Intangible Assets | 156.02 | 163.99 | 175.01 | 174.32 | 174.68 | 181.14 |
Long-Term Deferred Tax Assets | 4.21 | 4.84 | 30.32 | 20.39 | 17.82 | 12.35 |
Long-Term Deferred Charges | 223.06 | 283.61 | 293.89 | 270.65 | 194.9 | 97.87 |
Other Long-Term Assets | 29.82 | 6.03 | 48.57 | 45.5 | 49.34 | 67.81 |
Total Assets | 5,049 | 5,200 | 5,738 | 5,911 | 6,009 | 5,727 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 595.07 | 454.33 | 554.54 | 592.05 | 711.18 | 771.73 |
Accrued Expenses | 47.07 | 476.74 | 561.27 | 891.65 | 725.52 | 655.5 |
Short-Term Debt | 92.49 | 55.15 | 112.97 | 351.77 | 228.35 | 9.01 |
Current Portion of Long-Term Debt | 45.81 | 466.88 | 51.67 | 16.84 | - | - |
Current Portion of Leases | - | 4.78 | 9.23 | 10.34 | 9.68 | 4.77 |
Current Income Taxes Payable | 49.29 | 8.6 | 0.51 | 16.41 | 1.02 | 57.03 |
Current Unearned Revenue | 16.76 | 21.81 | 44.54 | 29.68 | 57.09 | 40.03 |
Other Current Liabilities | 403.05 | 188.99 | 170.77 | 227.89 | 166.51 | 144.13 |
Total Current Liabilities | 1,250 | 1,677 | 1,506 | 2,137 | 1,899 | 1,682 |
Long-Term Debt | 474.54 | 77.51 | 516.97 | 54.57 | - | - |
Long-Term Leases | 4.22 | 3.81 | 14.46 | 29.38 | 39.72 | 23.77 |
Long-Term Unearned Revenue | 123.81 | 123.64 | 116.21 | 93.05 | 72.32 | 93.7 |
Long-Term Deferred Tax Liabilities | 7.25 | 7.09 | - | - | - | - |
Total Liabilities | 1,859 | 1,889 | 2,153 | 2,314 | 2,011 | 1,800 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 450 | 450 | 450 | 450 | 450 | 450 |
Additional Paid-In Capital | 2,645 | 2,645 | 2,645 | 2,645 | 2,681 | 2,645 |
Retained Earnings | 215.19 | 320.08 | 582.47 | 547.65 | 857.86 | 828.56 |
Treasury Stock | -100.02 | -100.02 | -100.02 | -54.99 | - | - |
Comprehensive Income & Other | -0.04 | -0.03 | - | - | - | - |
Total Common Equity | 3,210 | 3,315 | 3,578 | 3,588 | 3,989 | 3,924 |
Minority Interest | -20.54 | -5 | 7.33 | 9.8 | 8.09 | 3.38 |
Shareholders' Equity | 3,190 | 3,310 | 3,585 | 3,598 | 3,997 | 3,927 |
Total Liabilities & Equity | 5,049 | 5,200 | 5,738 | 5,911 | 6,009 | 5,727 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 617.06 | 608.15 | 705.31 | 462.91 | 277.75 | 37.55 |
Net Cash (Debt) | 718.53 | 811.7 | 787.86 | 1,020 | 1,384 | 2,400 |
Net Cash Growth | 31.88% | 3.03% | -22.73% | -26.31% | -42.34% | 2.81% |
Net Cash Per Share | 1.64 | 1.83 | 1.78 | 2.26 | 3.05 | 5.32 |
Filing Date Shares Outstanding | 401.21 | 444.48 | 444.48 | 447.18 | 450 | 450 |
Total Common Shares Outstanding | 401.21 | 444.48 | 444.48 | 447.18 | 450 | 450 |
Working Capital | 1,224 | 911.87 | 1,652 | 1,288 | 2,002 | 2,384 |
Book Value Per Share | 8.00 | 7.46 | 8.05 | 8.02 | 8.87 | 8.72 |
Tangible Book Value | 3,054 | 3,151 | 3,403 | 3,414 | 3,815 | 3,743 |
Tangible Book Value Per Share | 7.61 | 7.09 | 7.66 | 7.63 | 8.48 | 8.32 |
Buildings | - | 1,424 | 1,417 | 1,314 | 1,127 | 1,135 |
Machinery | - | 1,225 | 1,203 | 1,166 | 958.27 | 871.85 |
Construction In Progress | - | 688.77 | 539.86 | 470.99 | 458.45 | 74.95 |